Carnyx Therapeutics
Company profile on P2PMarketData. Carnyx Therapeutics is a biotechnology company based in Indianapolis, IN, founded in 2024. It is raising on Equifund now.
Carnyx Therapeutics is a pre-clinical biotechnology company based in Indianapolis, Indiana. It is developing peptide therapeutics derived from Epitalon that are designed to support circadian sleep regulation and retinal photoreceptor function. Its lead programs include an oral compound intended to improve non-REM restorative sleep and an eye-drop therapy designed to address retinitis pigmentosa and macular degeneration.
Frequently asked questions about Carnyx Therapeutics
What is Carnyx Therapeutics' valuation?
Carnyx Therapeutics had an indicative valuation of $45M in its 2025 funding round.
Is Carnyx Therapeutics profitable?
No. Carnyx Therapeutics reported a net loss of $547.2K for fiscal year 2024.
Can I invest in Carnyx Therapeutics?
Yes. Carnyx Therapeutics has an open crowdfunding deal on Equifund.
When was Carnyx Therapeutics founded?
Carnyx Therapeutics was founded in June 2024.
Where is Carnyx Therapeutics based?
Carnyx Therapeutics is headquartered in Indianapolis, Indiana, United States, and is incorporated in Delaware, United States.
What industry is Carnyx Therapeutics in?
Carnyx Therapeutics operates in the Biotechnology industry within the Healthcare sector.